APA (7th ed.) Citation

Nguyen, D. T., Nguyen, D. H., & Nguyen, V. T. H. (2023). Sorafenib as first-line treatment for patients with primary hepatocellular carcinoma: An outcome evaluation. SAGE Publishing.

Chicago Style (17th ed.) Citation

Nguyen, Dung Thi, Duong Hoang Nguyen, and Van Thi Hong Nguyen. Sorafenib as First-line Treatment for Patients with Primary Hepatocellular Carcinoma: An Outcome Evaluation. SAGE Publishing, 2023.

MLA (9th ed.) Citation

Nguyen, Dung Thi, et al. Sorafenib as First-line Treatment for Patients with Primary Hepatocellular Carcinoma: An Outcome Evaluation. SAGE Publishing, 2023.